FeesSafety
Pluang+

Option Care Health Q3 revenue rises 4.1%, net income up 10.8%, merger deal underway

Company Fundamentals
04 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
Option Care Health Q3 revenue rises 4.1%, net income up 10.8%, merger deal underway

Option Care Health reported a 4.1% increase in net revenue to $1.49 billion for Q3 2026, with GAAP net income rising 10.8% to $57.4 million. Adjusted EBITDA grew 4.3% to $124.6 million, and adjusted diluted EPS increased 8.9% to $0.49. The company is set to be acquired by Clayton, Dubilier & Rice and McKesson, leading to the withdrawal of its financial guidance and no earnings call. This acquisition marks a significant strategic move for the largest independent home infusion provider in the U.S.

Option Care Health's Q3 2026 financial results provide context for readers following healthcare companies. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 18:41 WIB: Out of 150 priced US health stocks tradable on Pluang, 118 rose and 24 fell today. Notable movers include Novo Nordisk A/S (NVO) at USD 42.33 with a 5.32% increase and 90% buy order activity, HCA Health Inc (HCA) at USD 485.73 up 4.94%, and Tenet Healthcare Corporation (THC) at USD 279.75 with a 4.90% rise but 100% sell order activity.

More News

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
Bullish
32 minutes ago
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
Neutral
1 hour ago
etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...

Company Fundamentals
Bullish
1 hour ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
4 hours ago
KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App